Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort
Crossref DOI link: https://doi.org/10.1007/s00345-014-1375-5
Published Online: 2014-08-12
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Höfner, Thomas
Vallet, Sonia
Hadaschik, Boris A.
Pahernik, Sascha
Duensing, Stefan
Hohenfellner, Markus
Jäger, Dirk
Grüllich, Carsten
Text and Data Mining valid from 2014-08-12